Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 study evaluating a combination chemotherapy regimen with infusion of leukocytes in patients with hematologic cancers, which has co…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial evaluating azacitidine plus phenylbutyrate for acute myeloid leukemia or myelodysplastic syndromes has been completed…
-
CLINICAL_TRIALS trial_result · 2010-02-24Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma [Phase 2, Phase 3]
This clinical trial update covers Phase 2 and Phase 3 evaluation of bone marrow transplantation for patients with leukemia, myelodysplastic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluating darbepoetin alfa for treating anemia in patients with low-risk myelodysplastic syndromes, sponsored by A…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients. [Phase 2]
A Phase 2, multicenter, open-label, single-arm trial evaluating darbepoetin alfa for anemia in myelodysplastic syndromes has been terminated…
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. [Phase 2]
Phase 2 clinical trial evaluating donor umbilical cord blood natural killer cells with aldesleukin and umbilical cord blood transplant in re…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation [Phase 3]
This Phase 3 trial comparing peripheral blood versus bone marrow as graft sources in allogeneic stem cell transplantation has completed. It …
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid [Phase 2]
This document reports a Phase 2 clinical trial evaluating the combination of epoetin beta and all-trans retinoic acid for anemia in myelodys…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes [Phase 2]
Phase 2 study evaluating decitabine in adults with advanced myelodysplastic syndromes has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-09-03Clinical Trial Update: Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor umbilical cord blood transplant by intra-bone-marrow injection for hematologic cancers; trial term…
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial update evaluating amifostine with or without epoetin alfa in patients with myelodysplastic syndrome.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies [Phase 2]
A Phase 2 clinical trial from St. Jude evaluated haploidentical hematopoietic stem cell transplantation for treatment-refractory hematologic…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 3]
This is a Phase 3 trial evaluating combination chemotherapy with or without idarubicin followed by peripheral stem cell transplantation in p…
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT [Phase 2]
A Phase II trial evaluating busulfan and fludarabine as preparative conditioning therapy in adults with hematopoietic disorders undergoing m…
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) [Phase 2]
Phase 2 feasibility and efficacy study of a conditioning regimen using fludarabine, busulfan, and total body irradiation before allogeneic h…
-
CLINICAL_TRIALS trial_result · 2008-06-25Clinical Trial Update: Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of azacitidine in combination with thalidomide for higher-risk myelodysplastic syndromes.
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome [Phase 1, Phase 2]
Completed Phase 1/2 trial of TLK199 HCl liposomes for injection in myelodysplastic syndromes sponsored by Telik.
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Study of Velcade and Thalidomide in Patients With Myelodysplasia [Phase 1]
Phase 1 trial of Velcade (bortezomib) and thalidomide in patients with myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome [Phase 2]
This Phase 2 randomized trial comparing antithymocyte globulin to cyclosporine for cytopenia in myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase 2 randomized trial comparing daclizumab (anti-IL-2 receptor antibody) versus antithymocyte globulin for cytopenia in myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating HLA-mismatched peripheral blood stem cell transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: Darbepoetin Alpha in Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 clinical trial update assessing darbepoetin alfa in patients with myelodysplastic syndromes; current trial status is unknown.